American Vanguard (NYSE:AVD) Releases Quarterly Earnings Results, Misses Expectations By $0.21 EPS

American Vanguard (NYSE:AVD) released its quarterly earnings data on Friday. The basic materials company reported ($0.24) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.21), Zacks reports. American Vanguard had a negative net margin of 5.22% and a negative return on equity of 3.45%. The company had revenue of $127.00 million during the quarter, compared to the consensus estimate of $127.00 million. During the same quarter in the prior year, the company posted $0.06 earnings per share.

American Vanguard Stock Up 1.9%

NYSE:AVD opened at $4.95 on Friday. The stock’s fifty day moving average price is $4.18 and its two-hundred day moving average price is $4.81. American Vanguard has a 52-week low of $3.28 and a 52-week high of $9.84. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.79 and a current ratio of 1.89. The company has a market cap of $139.73 million, a price-to-earnings ratio of -4.81 and a beta of 1.28.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Strs Ohio acquired a new position in American Vanguard during the 1st quarter worth $28,000. Jane Street Group LLC increased its position in shares of American Vanguard by 287.6% in the 1st quarter. Jane Street Group LLC now owns 40,509 shares of the basic materials company’s stock valued at $178,000 after buying an additional 30,058 shares in the last quarter. Acadian Asset Management LLC increased its position in shares of American Vanguard by 1,732.4% in the 1st quarter. Acadian Asset Management LLC now owns 58,234 shares of the basic materials company’s stock valued at $253,000 after buying an additional 55,056 shares in the last quarter. Finally, AQR Capital Management LLC increased its position in shares of American Vanguard by 117.8% in the 1st quarter. AQR Capital Management LLC now owns 436,687 shares of the basic materials company’s stock valued at $1,921,000 after buying an additional 236,212 shares in the last quarter. Institutional investors and hedge funds own 79.04% of the company’s stock.

Analyst Ratings Changes

Separately, Wall Street Zen lowered American Vanguard from a “hold” rating to a “sell” rating in a research note on Saturday.

About American Vanguard

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.